Sign in
Taking peopleNo phase

Heart ultrasound to check the right heart side in sudden lung blood clots

Looks at heart ultrasound for strain on the right heart in pulmonary embolism.

Key facts

Who runs it
Sohag University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Risk Stratification and Prognostic Value of Right Ventricular Dysfunction Screening Using Transthoracic Echocardiography in Acute Pulmonary Embolism
Status
Recruiting
People taking part
112 people, planned
Started
1 Jun 2026
Expected to end
30 Nov 2026
Type of study
Observational
Treatments tested
  • Transthoracic Echocardiography
Record updated
15 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with a confirmed acute pulmonary embolism (a blood clot in the lungs). They must have had a heart ultrasound (transthoracic echocardiography) to check the right side of the heart.

Age
18 years and older
Sex
All sexes
Disease stage
Confirmed acute pulmonary embolism
Earlier treatment
Must have had a transthoracic echocardiography to check for right ventricular dysfunction (weak right heart chamber).

Main reasons for not taking part

  • Younger than 18 years
  • Incomplete clinical data
  • Did not have a transthoracic echocardiography

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Patients aged 18 years and older
  • Patients with a confirmed diagnosis of acute pulmonary embolism
  • Patients who underwent transthoracic echocardiographic assessment for right ventricular dysfunction

Who cannot take part

  • Patients younger than 18 years
  • Patients with incomplete clinical data
  • Patients who did not undergo transthoracic echocardiography

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This observational study evaluates right ventricular dysfunction in patients with acute pulmonary embolism using transthoracic echocardiography and assesses its prognostic significance and risk stratification value.

The group in the trial

  • Patients with acute pulmonary embolism

    Patients diagnosed with acute pulmonary embolism who undergo transthoracic echocardiographic assessment for evaluation of right ventricular dysfunction.

    Treatment: Transthoracic Echocardiography

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Risk Stratification and Prognostic Value of Right Ventricular Dysfunction Screening Using Transthoracic Echocardiography in Acute Pulmonary Embolism
Plain-language title
Heart ultrasound to check the right heart side in sudden lung blood clotsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Record updated
15 June 2026